Web Results

Patent Docs: Court Report


Apr 24, 2016 ... View the complaint here. Astrazeneca Pharmaceuticals LP et al. v. Mylan Pharmaceuticals Inc. et al. 1:15-cv-00183; filed October 15, 2015 in ...

Consolidated Profit & Loss Account For Ongoing ... - AstraZeneca

www.astrazeneca.com/content/dam/az/our-company/investor-relations/presentations-and-webcast/2010/Figures 2010 Q4 FY.PDF

Jan 12, 2011 ... Sweden, Germany, Belgium and Luxembourg) expired on 10 March 2010. ..... AstraZeneca Pharmaceuticals LP, AstraZeneca LP, et al.

743 million - SEC.gov


The number of outstanding shares of each class of stock of AstraZeneca PLC as of December 31, 2010 was: ..... weight loss compared to weight gain versus titrated glipizide plus metformin. ..... from marketing and selling generic esomeprazole products in Germany. .... AstraZeneca Pharmaceuticals LP, AstraZeneca LP, et al.

AstraZeneca Pharmaceuticals LP: Private Company Information ...


AstraZeneca Pharmaceuticals LP company research & investing information. Find executives and ... Ronald Streck versus Allergan, et al., Case No. 08-cv- 5135.

Representative Cases | Fitzpatrick, Cella, Harper & Scinto ...


Novartis Pharmaceuticals Corporation et al v. ... AstraZeneca Pharmaceuticals LP et al. v. ... AstraZeneca Pharmaceuticals LP and AstraZeneca UK Ltd., v.

AstraZeneca - Despite trend of therapeutic substitution, survey data ...


Dec 5, 2011 ... AstraZeneca reveals survey results and offers tips designed to help patients ... prescribed medication to a different drug in the same therapeutic category. ... bad cholesterol by up to 52% (at the 10-mg dose vs 7% with placebo). ... 1 Data on File, 1303202, AstraZeneca, LP. 2 Gray T, Bertch K, Galt K, et al.

Pharmaceutical Litigation | Sterne, Kessler, Goldstein & Fox


Sterne Kessler's pharmaceutical team brings together experienced attorneys and technical experts, ... New Drug Application (ANDA) case involving pioglitazone ( ACTOS®)); AstraZeneca Pharmaceuticals LP v. ... Chiron v. Eli Lilly (HCV Therapeutic). Glaxo Smith Kline v. Apotex et al. (Paxil®) .... 02.01.16 Berlin, Germany.

United States Court of Appeals for the Federal Circuit - US Court of ...


Apr 16, 2013 ... son Pharmaceuticals, Inc., et al. .... ority application filed in Germany. Bayer .... Indus. v. AstraZeneca Pharm. LP, 661 F.3d 1378, 1381 (Fed. Cir.

AstraZeneca - ZURAMPIC® (lesinurad) approved by US FDA for ...


Dec 22, 2015 ... AstraZeneca Pharmaceuticals LP, Wilmington, DE. Saag K, et al. Lesinurad, A Selective Uric Acid Reabsorption Inhibitor, In Combination With ...

Laura Lydigsen - Brinks Gilson & Lione


AstraZeneca LP et al v. Hisun Pharmaceutical (Hangzhou) Co., Ltd. et al., No. 1: 15-cv-1042 (D. Del. 2015-present). Representing client in Hatch-Waxman patent  ...

More Info



ASTRAZENECA PHARMACEUTICALS LP et al v. ... INC. sued by ASTRAZENECA PHARMACEUTICALS LP for patent infringement in District of New Jersey.

Download Q2 Interim financial statements PDF 1268KB


Palmetto Pharmaceuticals, LLC v. AstraZeneca .... In Germany, in December 2010 the court rejected AstraZeneca's request for preliminary injunctions to prevent Krka,. d.d., Novo .... AstraZeneca Pharmaceuticals LP, AstraZeneca LP, et al.

AstraZeneca Settles Generic Seroquel XR Row With Lupin - Law360


Apr 11, 2013 ... The case is Astrazeneca Pharmaceuticals LP et al. v. Lupin Ltd et al., case number 3:12-cv-06888, in the U.S. District Court for the District of ...